-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Metagenomi, Lowers Price Target to $7

Benzinga·04/03/2025 11:26:33
Listen to the news
HC Wainwright & Co. analyst Mitchell Kapoor maintains Metagenomi (NASDAQ:MGX) with a Buy and lowers the price target from $14 to $7.